Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to ease distress for young cancer survivors

NCT ID NCT04593277

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This completed study tested a program called INSPIRE-AYA for adolescent and young adult cancer survivors. The program used a mobile app, telehealth support, and educational materials to help survivors access healthcare resources and manage their health. Researchers measured changes in distress and healthcare adherence over 12 months in 549 participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California, 90095, United States

  • University of Pennsylvania/Abramson Cancer Center

    Philadelphia, Pennsylvania, 19104, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Interactive survivorship program (mobile app, telehealth, and educational materials)

What this could lead to

If successful, this program could become a standard way to help young cancer survivors manage their health and reduce distress after treatment.

What could go wrong

This is a completed study, but results are not yet widely implemented. The program may not work equally well for all survivors or in all healthcare settings.

Conditions

The condition(s) this trial relates to.

breast cancer cancer colorectal cancer colorectal neoplasm cutaneous melanoma hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm leukemia lymphoma melanoma sarcoma thyroid cancer thyroid gland carcinoma Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.